OssDsign is a Swedish Medtech company headquartered in Uppsala that researches, develops and delivers next generation orthobiological products. Since its establishment in 2011, the business has been based on cutting-edge materials science, developing and selling pharmaceuticals based on bioceramic materials whose composition is used to improve the healing process for various types of bone defects. The products are resold as implants and are mainly used for the treatment of head injuries.
The company’s product, OssDsign Catalyst® nanosynthetic bone graft, is designed to engage dual bone formation pathways, resulting in rapid and reliable bone formation at an early stage throughout the fusion mass. This supports the body’s own healing ability and gives patients back the life they deserve.
